Citadel Advisors LLC acquired a new stake in shares of Invizyne Technologies Inc. (NASDAQ:IZTC - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 27,652 shares of the company's stock, valued at approximately $456,000. Citadel Advisors LLC owned approximately 0.44% of Invizyne Technologies at the end of the most recent quarter.
Separately, Geode Capital Management LLC purchased a new position in shares of Invizyne Technologies during the 4th quarter worth approximately $277,000.
Invizyne Technologies Price Performance
Invizyne Technologies stock traded up $0.10 during mid-day trading on Wednesday, reaching $13.50. 3,522 shares of the company's stock were exchanged, compared to its average volume of 37,647. Invizyne Technologies Inc. has a twelve month low of $8.50 and a twelve month high of $23.00. The company has a fifty day moving average of $12.10 and a 200-day moving average of $14.13.
About Invizyne Technologies
(
Free Report)
Invizyne Technologies Inc is a cell-free enzyme-based biomanufacturing technology company. It redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources into highly sought after biochemicals. Invizyne Technologies Inc is based in Monrovia, CA.
Read More
Before you consider Invizyne Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Invizyne Technologies wasn't on the list.
While Invizyne Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
